• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环姜黄素是一种姜黄素衍生物,具有免疫调节能力,并且如MM-PBSA方法所预测的那样,是一种治疗类风湿性关节炎的潜在化合物。

Cyclocurcumin, a curcumin derivative, exhibits immune-modulating ability and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method.

作者信息

Fu Min, Chen Lihui, Zhang Limin, Yu Xiao, Yang Qingrui

机构信息

Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China.

出版信息

Int J Mol Med. 2017 May;39(5):1164-1172. doi: 10.3892/ijmm.2017.2926. Epub 2017 Mar 20.

DOI:10.3892/ijmm.2017.2926
PMID:28339004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5403524/
Abstract

The control and treatment of rheumatoid arthritis is a challenge in today's world. Therefore, the pursuit of natural disease-modifying antirheumatic drugs (DMRDs) remains a top priority in rheumatology. The present study focused on curcumin and its derivatives in the search for new DMRDs. We focused on prominent p38 mitogen-activated protein (MAP) kinase p38α which is a prime regulator of tumor necrosis factor-α (TNF-α), a key mediator of rheumatoid arthritis. In the present study, we used the X-ray crystallographic structure of p38α for molecular docking simulations and molecular dynamic simulations to study the binding modes of curcumin and its derivatives with the active site of p38α. The ATP-binding domain was used for evaluating curcumin and its derivatives. Molecular docking simulation results were used to select 4 out of 8 compounds. These 4 compounds were simulated using GROMACS molecular simulation platform; the results generated were subjected to molecular mechanics-Poisson Boltzmann surface area (MM-PBSA) calculations. The results showed cyclocurcumin as a potential natural compound for development of a potent DMRD. These data were further supported by inhibition of TNF-α release from lipopolysaccharide (LPS)-stimulated human macrophages following cyclocurcumin treatment.

摘要

类风湿性关节炎的控制和治疗是当今世界面临的一项挑战。因此,寻找天然的改善病情抗风湿药(DMRDs)仍然是风湿病学的首要任务。本研究聚焦于姜黄素及其衍生物,以寻找新型DMRDs。我们重点关注了突出的p38丝裂原活化蛋白(MAP)激酶p38α,它是肿瘤坏死因子-α(TNF-α)的主要调节因子,而TNF-α是类风湿性关节炎的关键介质。在本研究中,我们利用p38α的X射线晶体结构进行分子对接模拟和分子动力学模拟,以研究姜黄素及其衍生物与p38α活性位点的结合模式。ATP结合结构域用于评估姜黄素及其衍生物。分子对接模拟结果用于从8种化合物中筛选出4种。使用GROMACS分子模拟平台对这4种化合物进行模拟;对产生的结果进行分子力学-泊松玻尔兹曼表面积(MM-PBSA)计算。结果表明环姜黄素是开发强效DMRD的一种潜在天然化合物。环姜黄素处理后,脂多糖(LPS)刺激的人巨噬细胞中TNF-α释放受到抑制,进一步支持了这些数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/02c0362f0c70/IJMM-39-05-1164-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/434e68988707/IJMM-39-05-1164-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/dd7f1dfc7dbf/IJMM-39-05-1164-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/59d5cc686cb5/IJMM-39-05-1164-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/0bd894c54ac5/IJMM-39-05-1164-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/b205e22b3886/IJMM-39-05-1164-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/ef066dcd473f/IJMM-39-05-1164-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/b8539fe7902d/IJMM-39-05-1164-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/275be73f43cc/IJMM-39-05-1164-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/589db3cdb33c/IJMM-39-05-1164-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/02c0362f0c70/IJMM-39-05-1164-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/434e68988707/IJMM-39-05-1164-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/dd7f1dfc7dbf/IJMM-39-05-1164-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/59d5cc686cb5/IJMM-39-05-1164-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/0bd894c54ac5/IJMM-39-05-1164-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/b205e22b3886/IJMM-39-05-1164-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/ef066dcd473f/IJMM-39-05-1164-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/b8539fe7902d/IJMM-39-05-1164-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/275be73f43cc/IJMM-39-05-1164-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/589db3cdb33c/IJMM-39-05-1164-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f89c/5403524/02c0362f0c70/IJMM-39-05-1164-g09.jpg

相似文献

1
Cyclocurcumin, a curcumin derivative, exhibits immune-modulating ability and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method.环姜黄素是一种姜黄素衍生物,具有免疫调节能力,并且如MM-PBSA方法所预测的那样,是一种治疗类风湿性关节炎的潜在化合物。
Int J Mol Med. 2017 May;39(5):1164-1172. doi: 10.3892/ijmm.2017.2926. Epub 2017 Mar 20.
2
Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.新型p38丝裂原活化蛋白激酶抑制剂作为抗肿瘤坏死因子-α药物:N-[4-[2-乙基-4-(3-甲基苯基)-1,3-噻唑-5-基]-2-吡啶基]苯甲酰胺(TAK-715)作为一种强效口服活性抗类风湿关节炎药物的发现。
J Med Chem. 2005 Sep 22;48(19):5966-79. doi: 10.1021/jm050165o.
3
Cyclocurcumin as Promising Bioactive Natural Compound: An Overview.环姜黄素作为有前途的生物活性天然化合物:概述。
Molecules. 2024 Mar 24;29(7):1451. doi: 10.3390/molecules29071451.
4
Molecular docking studies of curcumin natural derivatives with DNA topoisomerase I and II-DNA complexes.姜黄素天然衍生物与DNA拓扑异构酶I和II-DNA复合物的分子对接研究。
Interdiscip Sci. 2014 Dec;6(4):285-91. doi: 10.1007/s12539-012-0048-6. Epub 2014 Aug 9.
5
Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines.不对称单羰基姜黄素类似物的合成及其对脂多糖诱导的小鼠和人巨噬细胞系中前列腺素E2生成的强效抑制作用。
Bioorg Med Chem Lett. 2016 May 15;26(10):2531-2538. doi: 10.1016/j.bmcl.2016.03.092. Epub 2016 Mar 26.
6
The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats.姜黄素及其纳米制剂对大鼠佐剂性关节炎的影响。
Drug Des Devel Ther. 2015 Aug 27;9:4931-42. doi: 10.2147/DDDT.S90147. eCollection 2015.
7
BDMC33, A curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways.姜黄素衍生物BDMC33在巨噬细胞样细胞系统中抑制炎症反应:对NF-κB和MAPK信号通路的抑制作用
Int J Mol Sci. 2012;13(3):2985-3008. doi: 10.3390/ijms13032985. Epub 2012 Mar 6.
8
Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages.姜黄素单羰基类似物的合成及其对 LPS 刺激的 RAW 264.7 巨噬细胞细胞因子释放抑制作用的影响。
Bioorg Med Chem. 2010 Apr 1;18(7):2388-93. doi: 10.1016/j.bmc.2010.03.001. Epub 2010 Mar 6.
9
Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.新型吡唑并嘧啶的合成、评价及对接研究作为强效 p38α MAP 激酶抑制剂,具有改善的抗炎、致溃疡和 TNF-α 抑制特性。
Bioorg Chem. 2019 Jun;87:550-559. doi: 10.1016/j.bioorg.2019.03.037. Epub 2019 Mar 15.
10
Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.姜黄素类似物 3,5-双(2-吡啶亚甲基)-4-哌啶酮(EF31)抑制 NF-κB 信号通路:抗炎和抗癌特性。
Int Immunopharmacol. 2012 Feb;12(2):368-77. doi: 10.1016/j.intimp.2011.12.009. Epub 2011 Dec 22.

引用本文的文献

1
Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights.用于克服姜黄素制剂挑战的纳米载体系统研究进展:当前见解
Nanomaterials (Basel). 2024 Apr 12;14(8):672. doi: 10.3390/nano14080672.
2
Cyclocurcumin as Promising Bioactive Natural Compound: An Overview.环姜黄素作为有前途的生物活性天然化合物:概述。
Molecules. 2024 Mar 24;29(7):1451. doi: 10.3390/molecules29071451.
3
Two-carbon tethered artemisinin-isatin hybrids: design, synthesis, anti-breast cancer potential, and study.双碳连接的青蒿素-异吲哚酮杂化物:设计、合成、抗乳腺癌潜力及研究

本文引用的文献

1
In silico analysis of the effect of mutation on epidermal growth factor receptor in non-small-cell lung carcinoma: from mutational analysis to drug designing.表皮生长因子受体非小细胞肺癌突变的计算机分析:从突变分析到药物设计。
J Biomol Struct Dyn. 2017 Feb;35(2):427-434. doi: 10.1080/07391102.2016.1146165. Epub 2016 Jul 29.
2
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
3
KAISO inhibition: an atomic insight.
Front Mol Biosci. 2023 Oct 19;10:1293763. doi: 10.3389/fmolb.2023.1293763. eCollection 2023.
4
To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds.探讨糖尿病肾病的潜在分子靶点及其利用潜在植物化合物的抑制作用。
Curr Med Chem. 2024;31(24):3752-3790. doi: 10.2174/0929867330666230519112312.
5
Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications: A comprehensive review.姜黄及其主要生物活性成分姜黄素对人类健康的影响:药物、医学和食品应用:综述
Front Nutr. 2023 Jan 10;9:1040259. doi: 10.3389/fnut.2022.1040259. eCollection 2022.
6
Biomedical Applications and Bioavailability of Curcumin-An Updated Overview.姜黄素的生物医学应用及生物利用度——最新综述
Pharmaceutics. 2021 Dec 7;13(12):2102. doi: 10.3390/pharmaceutics13122102.
7
Pharmacokinetics and tissue distribution of hydrazinocurcumin in rats.在大鼠体内的羟基姜黄素的药代动力学和组织分布。
Pharmacol Rep. 2021 Dec;73(6):1734-1743. doi: 10.1007/s43440-021-00312-5. Epub 2021 Jul 20.
8
Inhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP) induced neurotoxicity in differentiated PC12 cells.姜黄素和环姜黄素对分化 PC12 细胞中 1-甲基-4-苯基吡啶离子(MPP+)诱导的神经毒性的抑制作用。
Sci Rep. 2017 Dec 5;7(1):16977. doi: 10.1038/s41598-017-17268-3.
卡伊素抑制作用:原子层面的洞察。
J Biomol Struct Dyn. 2015;33(8):1794-804. doi: 10.1080/07391102.2014.974072. Epub 2014 Nov 5.
4
g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.g_mmpbsa——一种用于高通量MM-PBSA计算的GROMACS工具。
J Chem Inf Model. 2014 Jul 28;54(7):1951-62. doi: 10.1021/ci500020m. Epub 2014 Jun 19.
5
The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study.类风湿关节炎的全球负担:来自 2010 年全球疾病负担研究的估计。
Ann Rheum Dis. 2014 Jul;73(7):1316-22. doi: 10.1136/annrheumdis-2013-204627. Epub 2014 Feb 18.
6
When and where does inflammation begin in rheumatoid arthritis?类风湿关节炎中的炎症何时何地开始?
Curr Opin Rheumatol. 2014 Jan;26(1):64-71. doi: 10.1097/BOR.0000000000000017.
7
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.EULAR 推荐的治疗类风湿关节炎的合成和生物疾病修饰抗风湿药物:2013 更新版。
Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.
8
Proposal for a new nomenclature of disease-modifying antirheumatic drugs.疾病修饰抗风湿药物新命名法建议。
Ann Rheum Dis. 2014 Jan;73(1):3-5. doi: 10.1136/annrheumdis-2013-204317. Epub 2013 Sep 26.
9
Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.类风湿关节炎的流行病学、病理生理学和诊断概述。
Am J Manag Care. 2012 Dec;18(13 Suppl):S295-302.
10
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.291 种疾病和伤害导致的伤残调整生命年(DALYs)在 21 个地区,1990-2010 年:全球疾病负担研究 2010 的系统分析。
Lancet. 2012 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.